When compared to the PAN treated cohort, the group receiving MP intervention exhibited substantially reduced quantities of IL-1β and IL-18 at the same time point, while the RTX intervention led to significant reductions at both 24 and 48 h. This evidence concerns the gene IL18 and polyarteritis nodosa.